跳至主要内容
临床试验/NCT01348425
NCT01348425已完成不适用

Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent

Cook Group Incorporated8 个研究点 分布在 2 个国家目标入组 45 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
8
主要终点
Percent Change in Stent Length Upon Deployment

研究概览

简要总结

This randomized, post-market clinical study is intended to evaluate the delivery and deployment of longer Zilver PTX stents (≥ 100 mm) compared to shorter Zilver PTX stents (≤80 mm) for treatment of lesions of the above-the-knee femoropopliteal artery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • One de novo or restenosed artherosclerotic lesion with > 50% diameter stenosis
  • Reference vessel diameter of 4 - 9 mm
  • Rutherford category ≥ 2
  • Resting ankle brachial index < 0.9

排除标准

  • Prior stent in the study vessel
  • Significant stenosis (> 50%) or occlusion of inflow tract not successfully treated before the study procedure
  • Lacks at least one patent runoff vessel
  • Lesions requiring atherectomy, cutting balloons, cryoplasty balloons, or any other advanced device to facilitate stent delivery

结局指标

主要结局

Percent Change in Stent Length Upon Deployment

时间窗: During Procedure (day 1) (Prior to Stent Deployment and after Stent Deployment)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验